Symbols / HIND Stock $2.22 -2.20% Vyome Holdings, Inc.
HIND (Stock) Chart
About
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts.
Stock Fundamentals
Scroll to Statements| Market Cap | 15.58M | Enterprise Value | 12.30M | Income | -10.26M | Sales | 319.71K | Book/sh | 0.41 | Cash/sh | 0.71 |
| Dividend Yield | — | Payout | 0.00% | Employees | 9 | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | 48.73 | P/B | 5.38 | P/C | — | EV/EBITDA | -4.50 | EV/Sales | 38.48 |
| Quick Ratio | 1.86 | Current Ratio | 1.99 | Debt/Eq | 0.83 | LT Debt/Eq | — | EPS (ttm) | -4.86 | EPS next Y | — |
| EPS Growth | — | Revenue Growth | -40.50% | Earnings | 2025-11-14 | ROA | -43.58% | ROE | — | ROIC | — |
| Gross Margin | 68.43% | Oper. Margin | -37.07% | Profit Margin | 0.00% | Shs Outstand | 7.02M | Shs Float | 3.25M | Short Float | 3.52% |
| Short Ratio | 3.87 | Short Interest | — | 52W High | 56.40 | 52W Low | 1.75 | Beta | — | Avg Volume | 868.99K |
| Volume | 9.40K | Target Price | $15.00 | Recom | None | Prev Close | $2.27 | Price | $2.22 | Change | -2.20% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$15.00
Mean price target
2. Current target
$2.24
Latest analyst target
3. DCF / Fair value
$13.10
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.24
Low
$15.00
High
$15.00
Mean
$15.00
- Vyome gel cut severe cancer wound odor and pain in 14 days - Stock Titan Wed, 22 Apr 2026 12
- symbol__ Stock Quote Price and Forecast - CNN Sun, 17 Aug 2025 11
- Vyome Holdings (HIND) Stock: Why Institutions Watch It (Ticks Lower) 2026-04-18 - Shared Trade Ideas - UBND thành phố Hải Phòng Sat, 18 Apr 2026 13
- We're Not Very Worried About Vyome Holdings' (NASDAQ:HIND) Cash Burn Rate - Yahoo Finance Mon, 29 Dec 2025 08
- HIND Stock Price and Chart — NASDAQ:HIND - TradingView Fri, 05 Dec 2025 08
- HIND Stock Price, Quote & Chart | VYOME HOLDINGS INC (NASDAQ:HIND) - ChartMill Sat, 11 Oct 2025 00
- Vyome Holdings (HIND) Stock Consolidates (Eye on Rally) 2026-04-20 - Retail Money Flow - Xã Châu Thành Mon, 20 Apr 2026 15
- HIND Stock Rallies 70% Pre-Market Today – Find Out Why - Stocktwits Wed, 17 Sep 2025 07
- Vyome stock soars after analyst values lead drug candidate at $1 billion By Investing.com - Investing.com South Africa ue, 27 Jan 2026 08
- Hind Rectifiers Ltd is Rated Hold - Markets Mojo hu, 23 Apr 2026 05
- What is the current Price Target and Forecast for Vyome Holdings, Inc. (HIND) - Zacks Investment Research Fri, 26 Dec 2025 20
- How To Trade (HIND) (HIND:CA) - Stock Traders Daily Sun, 08 Mar 2026 08
- Vyome Holdings Stock Tumults After Strategic Moves in Europe - timothysykes.com ue, 27 Jan 2026 08
- HIND Forecast — Price Prediction for 2026. Should I Buy HIND? - Intellectia AI Fri, 23 Jan 2026 06
- HIND Forecast — Price Target — Prediction for 2027 - TradingView Wed, 12 Nov 2025 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.32
+24.43%
|
0.26
-38.23%
|
0.42
+8.64%
|
0.38
|
| Operating Revenue |
|
0.32
+24.43%
|
0.26
-38.23%
|
0.42
+8.64%
|
0.38
|
| Cost Of Revenue |
|
0.10
+62.88%
|
0.06
-53.55%
|
0.13
-43.65%
|
0.24
|
| Reconciled Cost Of Revenue |
|
0.10
+62.88%
|
0.06
-53.55%
|
0.13
-43.65%
|
0.24
|
| Gross Profit |
|
0.22
+12.21%
|
0.19
-30.99%
|
0.28
+93.36%
|
0.15
|
| Operating Expense |
|
2.97
+146.88%
|
1.20
+14.38%
|
1.05
-16.00%
|
1.25
|
| Research And Development |
|
0.59
+106.12%
|
0.29
-3.07%
|
0.29
-30.51%
|
0.42
|
| Selling General And Administration |
|
2.37
+163.26%
|
0.90
+18.89%
|
0.76
-8.56%
|
0.83
|
| Total Expenses |
|
3.07
+142.76%
|
1.26
+6.73%
|
1.18
-20.40%
|
1.49
|
| Operating Income |
|
-2.75
-172.97%
|
-1.01
-31.08%
|
-0.77
+30.47%
|
-1.10
|
| Total Operating Income As Reported |
|
-10.45
-938.67%
|
-1.01
-31.08%
|
-0.77
+30.47%
|
-1.10
|
| EBITDA |
|
-10.32
-742.99%
|
-1.22
-129.21%
|
-0.53
+50.28%
|
-1.07
|
| Normalized EBITDA |
|
-2.61
-113.51%
|
-1.22
-129.21%
|
-0.53
+50.28%
|
-1.07
|
| Reconciled Depreciation |
|
0.01
-30.91%
|
0.02
-18.15%
|
0.02
-62.26%
|
0.06
|
| EBIT |
|
-10.33
-732.17%
|
-1.24
-123.59%
|
-0.56
+50.88%
|
-1.13
|
| Total Unusual Items |
|
-7.71
|
0.00
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
-7.71
|
0.00
|
—
|
—
|
| Special Income Charges |
|
-7.71
|
0.00
|
—
|
—
|
| Restructuring And Mergern Acquisition |
|
7.71
|
0.00
|
—
|
—
|
| Net Income |
|
-10.26
-608.97%
|
-1.45
-101.06%
|
-0.72
+42.65%
|
-1.26
|
| Pretax Income |
|
-10.48
-623.87%
|
-1.45
-101.06%
|
-0.72
+42.65%
|
-1.26
|
| Net Non Operating Interest Income Expense |
|
-0.15
+28.82%
|
-0.21
-25.09%
|
-0.16
-31.76%
|
-0.12
|
| Interest Expense Non Operating |
|
0.15
-28.82%
|
0.21
+25.09%
|
0.16
+31.76%
|
0.12
|
| Net Interest Income |
|
-0.15
+28.82%
|
-0.21
-25.09%
|
-0.16
-31.76%
|
-0.12
|
| Interest Expense |
|
0.15
-28.82%
|
0.21
+25.09%
|
0.16
+31.76%
|
0.12
|
| Other Income Expense |
|
-7.58
-3125.64%
|
-0.24
-210.65%
|
0.21
+913.03%
|
-0.03
|
| Other Non Operating Income Expenses |
|
0.12
+151.68%
|
-0.24
-210.65%
|
0.21
+913.03%
|
-0.03
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-10.48
-623.87%
|
-1.45
-101.06%
|
-0.72
+42.65%
|
-1.26
|
| Net Income From Continuing Operation Net Minority Interest |
|
-10.26
-608.97%
|
-1.45
-101.06%
|
-0.72
+42.65%
|
-1.26
|
| Net Income From Continuing And Discontinued Operation |
|
-10.26
-608.97%
|
-1.45
-101.06%
|
-0.72
+42.65%
|
-1.26
|
| Net Income Continuous Operations |
|
-10.48
-623.87%
|
-1.45
-101.06%
|
-0.72
+42.65%
|
-1.26
|
| Minority Interests |
|
0.22
|
0.00
|
—
|
—
|
| Normalized Income |
|
-2.56
-76.62%
|
-1.45
-101.06%
|
-0.72
+42.65%
|
-1.26
|
| Net Income Common Stockholders |
|
-10.26
-608.97%
|
-1.45
-101.06%
|
-0.72
+42.65%
|
-1.26
|
| Diluted EPS |
|
—
|
-0.26
-852.54%
|
-0.03
+42.65%
|
-0.05
|
| Basic EPS |
|
—
|
-0.26
-852.54%
|
-0.03
+42.65%
|
-0.05
|
| Basic Average Shares |
|
—
|
5.57
-78.89%
|
26.37
+0.00%
|
26.37
|
| Diluted Average Shares |
|
—
|
5.57
-78.89%
|
26.37
+0.00%
|
26.37
|
| Diluted NI Availto Com Stockholders |
|
-10.26
-608.97%
|
-1.45
-101.06%
|
-0.72
+42.65%
|
-1.26
|
| Depreciation Amortization Depletion Income Statement |
|
0.01
-30.91%
|
0.02
|
—
|
—
|
| Depreciation And Amortization In Income Statement |
|
0.01
-30.91%
|
0.02
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
6.50
+370.28%
|
1.38
-2.79%
|
1.42
-20.57%
|
1.79
|
| Current Assets |
|
5.44
+1700.49%
|
0.30
+77.86%
|
0.17
-68.03%
|
0.53
|
| Cash Cash Equivalents And Short Term Investments |
|
4.98
+4789.24%
|
0.10
+512.15%
|
0.02
-96.37%
|
0.46
|
| Cash And Cash Equivalents |
|
4.98
+4789.24%
|
0.10
+512.15%
|
0.02
-96.37%
|
0.46
|
| Receivables |
|
0.10
+93.58%
|
0.05
-23.76%
|
0.07
+54667.21%
|
0.00
|
| Accounts Receivable |
|
0.00
-85.83%
|
0.00
-96.57%
|
0.07
+54667.21%
|
0.00
|
| Other Receivables |
|
0.10
+102.04%
|
0.05
|
—
|
—
|
| Prepaid Assets |
|
0.34
+1505.58%
|
0.02
|
0.00
-100.00%
|
0.03
|
| Current Deferred Assets |
|
0.00
-100.00%
|
0.11
|
—
|
—
|
| Other Current Assets |
|
0.02
+4.91%
|
0.02
-80.76%
|
0.09
+112.24%
|
0.04
|
| Total Non Current Assets |
|
1.06
-1.91%
|
1.08
-13.74%
|
1.25
-0.54%
|
1.26
|
| Net PPE |
|
0.08
-36.05%
|
0.12
-31.46%
|
0.17
+20.78%
|
0.14
|
| Gross PPE |
|
0.60
-9.93%
|
0.67
-20.22%
|
0.84
+6.48%
|
0.78
|
| Accumulated Depreciation |
|
-0.52
+4.27%
|
-0.55
+17.29%
|
-0.66
-3.28%
|
-0.64
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
0.12
-4.79%
|
0.13
-19.74%
|
0.16
+0.00%
|
0.16
|
| Machinery Furniture Equipment |
|
0.06
-15.53%
|
0.07
-33.00%
|
0.10
-0.36%
|
0.10
|
| Other Properties |
|
0.42
-10.54%
|
0.47
-18.16%
|
0.58
+9.75%
|
0.52
|
| Goodwill And Other Intangible Assets |
|
0.31
+0.00%
|
0.31
+0.00%
|
0.31
+0.00%
|
0.31
|
| Non Current Accounts Receivable |
|
0.60
-6.99%
|
0.65
-7.32%
|
0.70
-4.98%
|
0.73
|
| Non Current Deferred Assets |
|
—
|
—
|
0.07
+0.00%
|
0.07
|
| Non Current Prepaid Assets |
|
0.07
|
0.00
|
—
|
—
|
| Total Liabilities Net Minority Interest |
|
2.74
-52.62%
|
5.77
-23.10%
|
7.51
+4.92%
|
7.15
|
| Current Liabilities |
|
2.74
-52.35%
|
5.74
-11.38%
|
6.48
+32.03%
|
4.91
|
| Payables And Accrued Expenses |
|
2.46
+30.74%
|
1.88
-31.42%
|
2.74
+10.15%
|
2.49
|
| Payables |
|
1.82
+28.41%
|
1.41
-37.22%
|
2.25
+14.19%
|
1.97
|
| Accounts Payable |
|
0.65
+29.01%
|
0.50
-14.91%
|
0.59
+0.60%
|
0.59
|
| Other Payable |
|
0.96
+23.12%
|
0.78
-35.32%
|
1.21
+19.98%
|
1.01
|
| Current Accrued Expenses |
|
0.64
+37.84%
|
0.46
-4.43%
|
0.49
-5.40%
|
0.51
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.16
+12.54%
|
0.14
|
—
|
—
|
| Current Debt And Capital Lease Obligation |
|
0.03
-99.14%
|
3.62
+81.92%
|
1.99
+217.55%
|
0.63
|
| Current Debt |
|
—
|
3.59
+82.82%
|
1.96
+236.48%
|
0.58
|
| Other Current Borrowings |
|
—
|
3.59
+82.82%
|
1.96
+236.48%
|
0.58
|
| Current Capital Lease Obligation |
|
0.03
+11.54%
|
0.03
+11.93%
|
0.03
-41.32%
|
0.04
|
| Current Deferred Liabilities |
|
0.03
-31.99%
|
0.04
|
—
|
—
|
| Current Deferred Revenue |
|
0.03
-31.99%
|
0.04
|
—
|
—
|
| Other Current Liabilities |
|
0.06
-2.11%
|
0.06
-96.35%
|
1.75
-2.43%
|
1.79
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
-100.00%
|
0.03
-96.81%
|
1.03
-54.22%
|
2.25
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
-100.00%
|
0.03
-96.81%
|
1.03
-54.22%
|
2.25
|
| Long Term Debt |
|
—
|
—
|
0.97
-56.97%
|
2.25
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
0.03
-47.07%
|
0.06
|
0.00
|
| Stockholders Equity |
|
2.44
+155.61%
|
-4.39
+27.84%
|
-6.09
-13.42%
|
-5.37
|
| Common Stock Equity |
|
2.44
+155.61%
|
-4.39
+91.73%
|
-53.07
-1.38%
|
-52.35
|
| Capital Stock |
|
0.01
+197200.00%
|
0.00
-100.00%
|
46.99
+0.00%
|
46.99
|
| Common Stock |
|
0.01
|
0.00
-100.00%
|
0.00
+0.00%
|
0.00
|
| Preferred Stock |
|
0.00
-100.00%
|
0.00
-100.00%
|
46.98
+0.00%
|
46.98
|
| Share Issued |
|
5.92
+6.36%
|
5.57
-78.89%
|
26.37
+0.00%
|
26.37
|
| Ordinary Shares Number |
|
5.92
+6.36%
|
5.57
-78.89%
|
26.37
+0.00%
|
26.37
|
| Additional Paid In Capital |
|
90.08
+76.33%
|
51.08
+7836.02%
|
0.64
+0.00%
|
0.64
|
| Retained Earnings |
|
-87.56
-57.99%
|
-55.42
-2.77%
|
-53.93
-1.35%
|
-53.21
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.08
-48.32%
|
-0.05
-125.05%
|
0.21
-0.08%
|
0.21
|
| Minority Interest |
|
1.32
+131995700.00%
|
0.00
|
—
|
—
|
| Other Equity Adjustments |
|
-0.08
-48.32%
|
-0.05
-125.05%
|
0.21
-0.08%
|
0.21
|
| Total Equity Gross Minority Interest |
|
3.76
+185.67%
|
-4.39
+27.84%
|
-6.09
-13.42%
|
-5.37
|
| Total Capitalization |
|
2.44
+155.61%
|
-4.39
+14.20%
|
-5.12
-64.22%
|
-3.12
|
| Working Capital |
|
2.70
+149.71%
|
-5.44
+13.78%
|
-6.31
-44.17%
|
-4.37
|
| Invested Capital |
|
2.44
+404.64%
|
-0.80
+98.40%
|
-50.14
-1.25%
|
-49.52
|
| Total Debt |
|
0.03
-99.14%
|
3.65
+20.95%
|
3.02
+4.98%
|
2.87
|
| Net Debt |
|
—
|
3.49
+19.67%
|
2.91
+22.76%
|
2.37
|
| Capital Lease Obligations |
|
0.03
-48.63%
|
0.06
-30.10%
|
0.09
+104.05%
|
0.04
|
| Net Tangible Assets |
|
2.13
+145.22%
|
-4.71
+26.47%
|
-6.40
-12.68%
|
-5.68
|
| Tangible Book Value |
|
2.13
+145.22%
|
-4.71
+91.19%
|
-53.38
-1.37%
|
-52.66
|
| Dueto Related Parties Current |
|
0.20
+58.15%
|
0.13
-71.41%
|
0.45
+19.80%
|
0.38
|
| Preferred Stock Equity |
|
—
|
0.00
-100.00%
|
46.98
+0.00%
|
46.98
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-3.75
-510.43%
|
-0.61
-8.89%
|
-0.56
-55.42%
|
-0.36
|
| Cash Flow From Continuing Operating Activities |
|
-3.75
-510.43%
|
-0.61
-8.89%
|
-0.56
-55.42%
|
-0.36
|
| Net Income From Continuing Operations |
|
-10.48
-623.87%
|
-1.45
-101.06%
|
-0.72
+42.65%
|
-1.26
|
| Depreciation Amortization Depletion |
|
0.01
-30.91%
|
0.02
-18.15%
|
0.02
-62.26%
|
0.06
|
| Depreciation And Amortization |
|
0.01
-30.91%
|
0.02
-18.15%
|
0.02
-62.26%
|
0.06
|
| Other Non Cash Items |
|
0.10
-76.47%
|
0.43
+929.32%
|
-0.05
-118.91%
|
0.27
|
| Stock Based Compensation |
|
6.58
|
0.00
|
0.00
-100.00%
|
0.03
|
| Change In Working Capital |
|
0.04
-89.78%
|
0.39
+109.82%
|
0.19
-65.54%
|
0.54
|
| Change In Receivables |
|
—
|
—
|
-0.07
-87655.26%
|
-0.00
|
| Changes In Account Receivables |
|
—
|
—
|
-0.07
-87655.26%
|
-0.00
|
| Change In Inventory |
|
—
|
—
|
0.00
-100.00%
|
0.02
|
| Change In Prepaid Assets |
|
-0.43
-774.14%
|
0.06
+576.87%
|
-0.01
-106.56%
|
0.21
|
| Change In Payables And Accrued Expense |
|
0.25
+564.38%
|
0.04
-50.99%
|
0.08
-62.92%
|
0.20
|
| Change In Payable |
|
0.25
+564.38%
|
0.04
-50.99%
|
0.08
-62.92%
|
0.20
|
| Change In Account Payable |
|
0.17
+391.10%
|
-0.06
-120.39%
|
-0.03
-125.63%
|
0.10
|
| Change In Other Current Assets |
|
0.08
-3.51%
|
0.08
+638.78%
|
-0.01
+60.17%
|
-0.04
|
| Change In Other Current Liabilities |
|
0.15
-27.68%
|
0.21
+2.39%
|
0.21
+42.57%
|
0.14
|
| Investing Cash Flow |
|
0.00
-100.00%
|
0.00
+56.72%
|
0.00
+195.59%
|
0.00
|
| Cash Flow From Continuing Investing Activities |
|
0.00
-100.00%
|
0.00
+56.72%
|
0.00
+195.59%
|
0.00
|
| Net PPE Purchase And Sale |
|
0.00
-100.00%
|
0.00
+56.72%
|
0.00
+195.59%
|
0.00
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.00
+56.72%
|
0.00
+195.59%
|
0.00
|
| Financing Cash Flow |
|
8.65
+1140.05%
|
0.70
+470.46%
|
0.12
-83.74%
|
0.75
|
| Cash Flow From Continuing Financing Activities |
|
8.65
+1140.05%
|
0.70
+470.46%
|
0.12
-83.74%
|
0.75
|
| Net Issuance Payments Of Debt |
|
0.79
+18.63%
|
0.67
+344.67%
|
0.15
-79.31%
|
0.72
|
| Issuance Of Debt |
|
0.79
+18.63%
|
0.67
+344.67%
|
0.15
-79.31%
|
0.72
|
| Long Term Debt Issuance |
|
0.60
|
0.00
-100.00%
|
0.15
-79.31%
|
0.72
|
| Net Long Term Debt Issuance |
|
0.60
|
0.00
-100.00%
|
0.15
-79.31%
|
0.72
|
| Short Term Debt Issuance |
|
0.19
-71.33%
|
0.67
+344.67%
|
0.15
-79.31%
|
0.72
|
| Net Short Term Debt Issuance |
|
0.19
-71.33%
|
0.67
+344.67%
|
0.15
-79.31%
|
0.72
|
| Net Common Stock Issuance |
|
7.86
|
0.00
|
—
|
—
|
| Proceeds From Stock Option Exercised |
|
0.01
|
0.00
|
—
|
—
|
| Net Other Financing Charges |
|
—
|
0.03
+211.90%
|
-0.03
-200.00%
|
0.03
|
| Changes In Cash |
|
4.91
+5731.60%
|
0.08
+119.06%
|
-0.44
-213.23%
|
0.39
|
| Effect Of Exchange Rate Changes |
|
-0.03
-2379.86%
|
0.00
+787.20%
|
-0.00
-178.85%
|
0.00
|
| Beginning Cash Position |
|
0.10
+512.15%
|
0.02
-96.37%
|
0.46
+571.94%
|
0.07
|
| End Cash Position |
|
4.98
+4789.24%
|
0.10
+512.15%
|
0.02
-96.37%
|
0.46
|
| Free Cash Flow |
|
-3.75
-510.43%
|
-0.61
-8.89%
|
-0.56
-55.42%
|
-0.36
|
| Interest Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
7.86
|
0.00
|
—
|
—
|
| Issuance Of Capital Stock |
|
7.86
|
0.00
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-K2026-03-18 View
- 8-K2026-02-25 View
- 8-K2026-02-13 View
- 8-K2026-01-28 View
- 8-K2025-12-23 View
- 8-K2025-11-19 View
- 42025-11-19 View
- 42025-11-18 View
- 42025-11-17 View
- 42025-11-17 View
- 42025-11-17 View
- 10-Q2025-11-14 View
- 8-K2025-10-30 View
- 8-K2025-10-03 View
- 42025-09-22 View
- 42025-09-11 View
- 8-K2025-09-02 View
- 8-K2025-08-20 View
- 8-K2025-08-19 View
- 10-Q2025-08-14 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|